Literature DB >> 17576318

Activity and post antifungal effect of chlorpromazine and trifluopherazine against Aspergillus, Scedosporium and zygomycetes.

Roxana G Vitale1, Javier Afeltra, Jacques F G M Meis, Paul E Verweij.   

Abstract

The phenothiazine compounds chlorpromazine and trifluopherazine are antipsychotic agents that exhibit antimicrobial activity against bacteria, some protozoa and yeasts. Data of activity against filamentous fungi are lacking. The in vitro activity and postantifungal effect (PAFE) of chlorpromazine and trifluopherazine was determined against Aspergillus species, zygomycetes and Scedosporium species. In vitro susceptibility testing was performed with CLSI M38A and the PAFE was determined with previously established methods. Both drugs inhibited the growth of all fungi tested at concentrations of 16 to 64 microg ml(-1). For Aspergillus species the mean PAFE was 3.7 and 4.7 h; for zygomycetes, 3.1 and 3.4 h; for Scedosporium, 4.3 and 5.3 h for chlorpromazine and trifluoroperazine respectively. These are the first drugs shown to induce PAFE against Scedosporium. We show that phenothiazine compounds have in vitro antifungal activity and exhibit PAFE against a broad range of filamentous fungal pathogens. Although the exact mechanism of action is unknown, further studies are needed to explore the clinical usefulness of phenothiazine compounds.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17576318     DOI: 10.1111/j.1439-0507.2007.01371.x

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  9 in total

Review 1.  Therapeutic Challenges of Non-Aspergillus Invasive Mold Infections in Immunosuppressed Patients.

Authors:  Frederic Lamoth; Dimitrios P Kontoyiannis
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

2.  Thioridazine inhibits gene expression control of the cell wall signaling pathway (CWI) in the human pathogenic fungus Paracoccidioides brasiliensis.

Authors:  Daniela Leite Jabes; Ana Claudia de Freitas Oliveira; Valquíria Campos Alencar; Fabiano Bezerra Menegidio; Débora Liliane Souza Reno; Daiene Souza Santos; David Aciole Barbosa; Renata Ozelami Vilas Boas; Rodrigo Luiz de Oliveira Rodrigues Cunha; Tiago Rodrigues; Regina Costa de Oliveira; Luiz R Nunes
Journal:  Mol Genet Genomics       Date:  2016-03-08       Impact factor: 3.291

3.  In vitro synergistic effects of chlorpromazine and sertraline in combination with amphotericin B against Cryptococcus neoformans var. grubii.

Authors:  Luana Rossato; Érico S Loreto; Régis A Zanette; Francieli Chassot; Janio M Santurio; Sydney H Alves
Journal:  Folia Microbiol (Praha)       Date:  2016-02-04       Impact factor: 2.099

4.  The Repurposing of Anti-Psychotic Drugs, Quetiapine and Olanzapine, as Anti-Cryptococcus Drugs.

Authors:  Adepemi O Ogundeji; Carolina H Pohl; Olihile M Sebolai
Journal:  Front Microbiol       Date:  2017-05-09       Impact factor: 5.640

5.  A Unique Dual-Readout High-Throughput Screening Assay To Identify Antifungal Compounds with Aspergillus fumigatus.

Authors:  Sarah R Beattie; Damian J Krysan
Journal:  mSphere       Date:  2021-08-18       Impact factor: 4.389

6.  Antifungal Phenothiazines: Optimization, Characterization of Mechanism, and Modulation of Neuroreceptor Activity.

Authors:  Marhiah C Montoya; Louis DiDone; Richard F Heier; Marvin J Meyers; Damian J Krysan
Journal:  ACS Infect Dis       Date:  2017-11-02       Impact factor: 5.084

Review 7.  Drug Repurposing in Medical Mycology: Identification of Compounds as Potential Antifungals to Overcome the Emergence of Multidrug-Resistant Fungi.

Authors:  Lucie Peyclit; Hanane Yousfi; Jean-Marc Rolain; Fadi Bittar
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-20

Review 8.  Drug repurposing strategies in the development of potential antifungal agents.

Authors:  Qian Zhang; Fangyan Liu; Meng Zeng; Yingyu Mao; Zhangyong Song
Journal:  Appl Microbiol Biotechnol       Date:  2021-06-21       Impact factor: 4.813

9.  Galleria mellonella as an insect model for P. destructans, the cause of White-nose Syndrome in bats.

Authors:  Chapman N Beekman; Lauren Meckler; Eleanor Kim; Richard J Bennett
Journal:  PLoS One       Date:  2018-09-05       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.